NeuBase Therapeutics Price on May 6, 2024
NBSEDelisted Stock | USD 1.62 0.17 9.50% |
If you're considering investing in NeuBase Stock, it is important to understand the factors that can impact its price. As of today, the current price of NeuBase Therapeutics stands at 1.62, as last reported on the 2nd of December, with the highest price reaching 1.83 and the lowest price hitting 1.60 during the day. We have found twenty-three technical indicators for NeuBase Therapeutics, which you can use to evaluate the volatility of the firm. Please verify NeuBase Therapeutics' Risk Adjusted Performance of (0.12), mean deviation of 4.27, and Standard Deviation of 6.12 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
NeuBase Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NeuBase |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
NBSE |
Based on monthly moving average NeuBase Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeuBase Therapeutics by adding NeuBase Therapeutics to a well-diversified portfolio.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About NeuBase Therapeutics Stock history
NeuBase Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeuBase is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeuBase Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeuBase Therapeutics stock prices may prove useful in developing a viable investing in NeuBase Therapeutics
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania. Neu Base operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 33 people.
NeuBase Therapeutics Stock Technical Analysis
NeuBase Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
NeuBase Therapeutics Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
NeuBase Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NeuBase Therapeutics December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how NeuBase Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuBase Therapeutics shares will generate the highest return on investment. By undertsting and applying NeuBase Therapeutics stock market strength indicators, traders can identify NeuBase Therapeutics entry and exit signals to maximize returns
NeuBase Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NeuBase Therapeutics' price direction in advance. Along with the technical and fundamental analysis of NeuBase Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeuBase to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.12) | |||
Jensen Alpha | (1.04) | |||
Total Risk Alpha | (2.05) | |||
Treynor Ratio | (8.65) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in NeuBase Stock
If you are still planning to invest in NeuBase Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuBase Therapeutics' history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |